Intervention: Rehabilitation

All non-pharmacological interventions based on physical or cognitive rehabilitation of the patient

RELOAD

Germany
|
2022-2024
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

REHABCOVID

Spain
|
2023-2024
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

PuRe-COVID

Belgium
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Plaza

Spain
|
2023-2025
  • Adults (18-64 years)
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Peghetti

Italy
|
2021-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Oliván-Blázquez

Spain
|
2022
  • Adults (18-64 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

MULTI-COVID

Italy
|
2023-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Mischke

Germany
|
2023
  • Adults (18-64 years)
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

Merinero

Spain
|
2024-2025
  • Adults (18-64 years)
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

Matias-Guiu

Spain
|
2023-2024
  • Adults (18-64 years)
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Kroemer

Germany
|
2024-2027
  • Adults (18-64 years)
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

InvidiCO

Germany
|
2024-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Vimida